Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$28,835,679
+$909,529 QoQ
Shares Held
114,591
-10.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.77%
of 13F equity value
Holder Rank
#497
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $75,110,921 across 10 Drug Manufacturers - General names. ABBV ranks #1 (38.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
114,591 | $28,835,679 | |
| 2 | JNJ |
Johnson & Johnson
|
79,895 | $20,290,932 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
67,003 | $8,465,159 | |
| 4 | LLY |
ELI LILLY & Co
|
4,621 | $5,542,566 | |
| 5 | NVS |
Novartis AG
|
32,039 | $5,021,152 | |
| 6 | MRK |
Merck & Co., Inc.
|
28,921 | $3,716,348 | |
| 7 | GSK |
GSK plc
|
23,142 | $1,213,103 | |
| 8 | PFE |
Pfizer Inc
|
40,635 | $978,490 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,835,679 | 114,591 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $27,926,150 | 128,402 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $32,434,383 | 141,951 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $40,298,610 | 174,046 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $32,395,330 | 174,525 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,091,915 | 172,260 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $37,697,633 | 212,142 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $42,341,094 | 214,407 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $37,703,011 | 219,817 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $40,402,891 | 221,872 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $46,833,018 | 302,207 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $46,007,369 | 308,650 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $41,559,085 | 308,462 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $49,089,784 | 308,024 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $49,612,169 | 306,987 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $36,050,282 | 268,611 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $41,107,837 | 268,398 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $43,564,630 | 268,735 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,222,591 | 16,415 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,821,816 | 16,889 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,912,514 | 16,979 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,812,035 | 16,744 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,842,765 | 17,198 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,264,098 | 14,432 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,430,482 | 14,570 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,045,250 | 13,719 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||